Market Entry · Business setup

Choosing and appointing a superintendent pharmacist: duties and due diligence

Appointing a superintendent pharmacist is the one hire a pharmacy company cannot trade without, and in 2026 it is a hire being made against a rising bar: the General Pharmaceutical Council (GPhC) consulted on new superintendent standards between December 2025 and March 2026, with the final standards due before December 2026. This guide covers what the law already requires of the appointee, what is about to be added, how an owner should run the diligence, what a pharmacist should check before accepting and what the appointment agreement itself must contain. It is written for both sides of the table, because the appointments that fail are the ones where only one side did the checking.

Last reviewed 7 July 2026 by Arham Jamaal, Superintendent Pharmacist. Referenced against the sources cited in this article.

Why is the superintendent appointment the most important hire in a pharmacy business?

Because the company's right to trade rests on it. A body corporate can only lawfully carry on a retail pharmacy business if a superintendent pharmacist is appointed under whose management the professional business is carried on, so the appointment is not senior staffing, it is a condition of lawfulness. Lose the superintendent without a successor and the business does not have a vacancy, it has a legal problem.

The role also concentrates the regulatory relationship. The GPhC holds the superintendent professionally accountable for the safe and effective running of the pharmacy, NHS fitness checks examine them alongside the directors, and as we put it in the GPhC premises application, the justification for why the pharmacy's arrangements meet the standards is the superintendent's to make and defend, not the regulator's to supply. For a non-pharmacist owner, whose lawful ownership exists precisely because a named pharmacist has accepted this accountability, the quality of this appointment is the load-bearing wall of the entire structure described in structuring a pharmacy business.

Treat the appointment accordingly: as a two-way professional commitment negotiated in writing, not a name sourced for a form.

Since 1 December 2022, section 71 of the Medicines Act 1968 as amended requires the superintendent to be a pharmacist who is a senior manager of the retail pharmacy business, with authority to make decisions affecting the retail sale and supply of medicines, and the appointment must be recorded in a written statement signed by both the superintendent and the body corporate and sent to the registrar. The senior manager test is one of substance: a person plays a significant role in the decisions that matter, and a superintendent who can be overruled on how medicines are sold and supplied does not meet the statutory description, whatever their title says.

Two further legal boundaries shape every appointment. A superintendent serves one operating body corporate at a time, with the NHS England Pharmacy Manual permitting a second only for the purpose of submitting an application rather than operating pharmacies, so a pharmacist cannot superintend two trading companies and a group cannot stretch one superintendent across its subsidiaries. And the superintendent role is distinct from the responsible pharmacist role, which attaches to each premises whenever it operates; one person can hold both in a small business, but the accountabilities are separate and the incoming standards address exactly that interplay.

What is changing in 2026?

The role is being codified. The GPhC ran a public consultation from 17 December 2025 to 25 March 2026 on new standards for superintendent pharmacists and responsible pharmacists, together with rules for responsible pharmacists, and has committed to publishing the final standards and rules before the remaining pharmacy supervision legislation takes effect on 10 December 2026. The consultation sits inside the wider supervision reforms: since 7 January 2026 pharmacists have been able to authorise any member of the pharmacy team to hand out checked and bagged prescriptions in a pharmacist's absence, and from 10 December 2026 pharmacists will be able to authorise registered pharmacy technicians to carry out or supervise the preparation, assembly, dispensing and sale and supply of medicines.

APPOINT TO THE INCOMING BAR

An appointment structured casually in mid 2026 may need restructuring within months. The practical hedge costs nothing: give the superintendent real authority, document the governance around them properly and write the agreement so that compliance with GPhC standards as amended from time to time is a term of the appointment, and the December publication becomes an update rather than a renegotiation.

There is a strategic layer too. The supervision reforms exist to push pharmacists towards clinical services, and they make the superintendent's judgement more consequential, not less, because delegation decisions, authorisation frameworks and the SOPs that carry them are exactly the arrangements the superintendent must be able to justify.

"A superintendent hired for a signature will be underwater by December; a superintendent hired for judgement will be the reason the business adapts well."

How should an owner choose a superintendent?

Choose for verified history, model fit and genuine capacity, in that order, and verify everything independently before the appointment statement is signed. The diligence is not elaborate, but every element of it exists because someone, somewhere, skipped it.

Verify the registration and the history. Check the pharmacist on the GPhC register yourself, including any conditions or fitness-to-practise history, and ask directly about anything regulatory in their past; disclosed history can often be managed, discovered history cannot. NHS applications will require references from recent posts for pharmacist superintendents, so gather them now rather than at application.

Test the model fit. A superintendent whose whole career is walk-in community dispensing will be learning distance selling on your registration. For an online model, probe their fluency in remote pathways, identity verification, the GPhC's distance services guidance and, bluntly, whether they can write and defend SOPs for a pharmacy patients never visit, since that defence is the heart of the role as covered in superintendent pharmacist responsibilities in an online pharmacy.

Confirm real capacity. The senior manager test makes drive-by superintendency legally fragile. Ask what else they superintend (the answer must be nothing else operating), what days they will actually be in the business and how they will discharge the role during your launch, inspection and growth phases.

Check conflicts and incentives. A superintendent with interests in a competing pharmacy, a supplier or a prescriber your pharmacy depends on needs those interests declared and managed in the agreement, not discovered later.

Owner checks before appointingPharmacist checks before accepting
GPhC register entry, conditions, fitness-to-practise historyWritten confirmation of senior manager authority over sale and supply of medicines
References from recent posts, gathered to NHS standardGovernance access: board reporting line, right to be heard before decisions affecting medicines
Sector and model fit, especially for distance sellingThe business's actual compliance state: SOPs, premises, incident history, honestly disclosed
Capacity: no other operating body corporate, real time committedProfessional indemnity covering the superintendent role and the online model specifically
Conflicts of interest declared and manageableBudget authority or escalation route for compliance spending
Willingness to be present through application, launch and inspectionNotice, succession and what happens to the role on ownership disputes

What should a pharmacist check before accepting?

A pharmacist considering an appointment is being asked to attach their registration to someone else's business, so the diligence runs just as hard in reverse: never accept a superintendency on goodwill and a job title. The statutory senior manager requirement is the pharmacist's shield as much as the owner's obligation, and it should be made real in writing before the statement goes to the registrar.

Concretely, that means: authority over the sale and supply of medicines stated in the appointment terms, with a defined escalation route if the board and the superintendent disagree; access to the information the accountability requires, from incident logs to supplier contracts to the premises itself; an honest picture of the business being taken on, because accepting the role means inheriting its compliance state, and a superintendent who signs on without reading the SOPs and the last inspection outcome is accepting risk blind; indemnity insurance that explicitly covers the superintendent role in the model being operated; and a route to resign that does not trap the pharmacist in post during a dispute, balanced against the business's need for succession notice.

The moment to secure all of this is before acceptance, when the pharmacist's leverage is at its maximum. A business that resists writing the superintendent's authority down is telling the pharmacist exactly how the role will be treated after the ink dries, and that is information worth acting on.

What belongs in the appointment agreement?

The agreement should make the statutory position contractual: scope, authority, time, money, succession and the interface with the corporate documents, all in writing, whichever side of the table you sit on. The signed statement to the registrar records that an appointment exists; the agreement is what makes it work.

Scope and authority. The role defined against section 71 and against GPhC standards as amended from time to time, with the senior manager authority over the retail sale and supply of medicines stated expressly and the escalation route for disagreement defined.

Time and presence. The expected commitment, in days or sessions, and how it flexes across launch, inspection and steady state, so that neither side discovers the other's assumptions at the worst moment.

Remuneration. The market runs on a few structural patterns rather than a standard price: an owner-superintendent taking the role inside their overall position; an employed pharmacist carrying the role with a salary uplift; an external superintendent on a retainer scaled to involvement; and, in founder-heavy businesses, equity or profit participation aligning the superintendent with the outcome. Which pattern fits depends on capacity and model, but the principle holds across all of them: pay for the accountability, not the signature, because underpaid superintendency buys exactly the level of attention it prices.

Succession and exit. Notice periods long enough to recruit a successor, cooperation obligations through the handover and the registrar notification, and, where the superintendent is also a shareholder, the interlock with the shareholders' agreement so that a corporate dispute cannot cost the business its superintendent overnight, a point argued in structuring a pharmacy business.

Conflicts and confidentiality. Declared interests, how new ones are notified and the confidentiality obligations that survive exit.

What does the role involve day to day?

Day to day, the superintendent owns the professional integrity of the whole operation: the SOP suite and its justification, clinical governance and incident learning, the compliance calendar, the standards evidence an inspector will test and, in an online pharmacy, the safety of every remote pathway from questionnaire to dispatch. This article deliberately stops at the summary, because the working content of the role in an internet pharmacy, from the distance services guidance to prescriber oversight to what the GPhC actually holds superintendents to account for, has its own dedicated treatment in superintendent pharmacist responsibilities in an online pharmacy. Read that one before the appointment is agreed, whichever side you are on, because the diligence in this article only makes sense against an accurate picture of what is being taken on.

Key takeaways

  • A body corporate cannot lawfully run a pharmacy without a superintendent pharmacist, which makes the appointment a condition of trading rather than a staffing decision.
  • Since December 2022 the superintendent must be a senior manager with real authority over the sale and supply of medicines, recorded in a statement signed by both parties and sent to the registrar.
  • One pharmacist can superintend only one operating body corporate, so groups need a superintendent per trading company.
  • New GPhC standards for superintendent pharmacists were consulted on until 25 March 2026 and will be published before 10 December 2026, so appoint to the incoming bar and make ongoing standards compliance a contract term.
  • Owners should verify registration history, model fit, capacity and conflicts independently before signing; pharmacists should secure written authority, governance access, indemnity and an honest picture of the business before accepting.
  • Pay for accountability rather than a signature, using whichever structural pattern fits, from owner-superintendent to retainer to equity participation.
  • Interlock the appointment agreement with the shareholders' agreement so that corporate disputes cannot strip the business of its superintendent overnight.

FAQs

No. The superintendent must be a registered pharmacist, which is precisely why the appointment is the critical hire for non-pharmacist owners: the law permits them to own the business only on the condition that a pharmacist holds this accountability.
AJ
WRITTEN BY
Arham Jamaal
Superintendent Pharmacist · Published researcher, pharmacokinetics
This article is general guidance for pharmacy professionals and does not constitute legal or employment advice; appointment agreements and shareholder arrangements need advice from qualified professionals on your specific facts. Check current guidance from the GPhC before acting, particularly once the new superintendent standards publish in 2026. Last reviewed 7 July 2026.

Appoint for judgement.

The superintendent appointment sits inside almost every market entry our publisher supports, whether the founder is the superintendent or one is being recruited, and the appointment documentation, governance design and SOP suite the role must defend are work we do daily, informed by holding the role ourselves. If you are appointing, or being appointed, and want a second pair of eyes on the structure, book a 30-minute call.

Book a call

Keep reading